Default judgment creates immediate and material legal liability for Agenus. The damages amount will be known when Medpace files its proposed judgment by December 10, 2025. Given the company's $135M market cap, even a mid-range contract dispute award could be significant. Monitor for the proposed judgment filing and any subsequent settlement or appeal efforts.
AGEN drugs
AGEN drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Dec 5 $3.93entry
- T+1 · 11mo ago +2.54%α +2.85% · $4.03
- T+5 · 11mo ago −3.56%α −2.99% · $3.79
- T+20 · 11mo ago −11.70%α −12.90% · $3.47
- T+60 · 9mo ago −25.70%α −25.35% · $2.92
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Agenus Inc. and its CEO Garo Armen had their answers stricken and default judgment entered against them in a breach-of-contract and breach-of-fiduciary-duty lawsuit brought by Medpace, Inc. The court found that Agenus engaged in a 'complete, sustained and deliberate' pattern of discovery noncompliance, including failing to respond to the sanctions motion. This ruling creates immediate financial liability for Agenus, with the damages amount to be determined in a proposed judgment due by December 10, 2025.
Court Ruling Details
Key Facts
- Default judgment entered against Agenus Inc. and Garo Armen in Medpace, Inc. v. Agenus Inc. et al. (S.D.N.Y., 25-CV-4179)
- Court found 'complete, sustained and deliberate' discovery noncompliance by Agenus
- Defendants' answers stricken; default judgment granted to Medpace
- Medpace must file a proposed judgment by December 10, 2025
- Agenus failed to oppose the sanctions motion despite being given the opportunity
- Case involves breach of contract and breach of fiduciary duty claims
Financial Impact
Damages to be determined; Medpace will file a proposed judgment by December 10, 2025. The ruling grants default judgment, meaning Agenus faces liability on the merits of the breach-of-contract and breach-of-fiduciary-duty claims.
Risk Factors
- Damages award could be material relative to $135M market cap
- Default judgment may trigger cross-defaults or covenant violations in debt agreements
- CEO Garo Armen is also a named defendant, creating personal liability risk
- Potential for additional sanctions or attorney's fees to be awarded
- Negative reputational impact from judicial finding of deliberate discovery abuse
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-24xutg8h-AGEN |
Track record
12 reports on AGEN
2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +138.65% at T+60 after the May 11, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $6.35 Now $6.29 −0.94% settles Feb 16
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $6.97 Now $6.29 −9.76% settles Feb 12
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $6.44 Now $6.29 −2.33% settles Feb 3
- Aug 12, 202613w ago 8-K Neutral 2/10 Entry $7.00 to $6.90 Now $6.29 −10.14% ▼ −1.43% +3.81% vs SPY
- Aug 12, 202613w ago Institutional Cluster Mixed 4/10 Entry $6.90 to $6.97 Now $6.29 −8.84% ▲ +1.01% +5.89% vs SPY
- Aug 7, 202614w ago S-3 Bearish 7/10 Entry $7.00 to $6.76 Now $6.29 +10.14% ▲ +3.43% +1.53% vs SPY
- Aug 6, 202614w ago 8-K Neutral 5/10 Entry $7.49 to $6.84 Now $6.29 −16.02% ▼ −8.68% −7.01% vs SPY
- Jul 17, 202617w ago S-3 Bearish 5/10 Entry $4.97 to $6.95 Now $6.29 −26.56% ▼ −39.84% −35.00% vs SPY
- Jul 13, 202618w ago 8-K Bearish 6/10 Entry $6.12 to $7.49 Now $6.29 −2.78% ▼ −22.39% −18.39% vs SPY
- May 13, 202626w ago DEFA14A Neutral 4/10 Entry $3.47 to $6.96 Now $6.29 +81.27% ▲ +100.58% +96.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers